Literature DB >> 9888391

Mutation analyses of North American APS-1 patients.

M Heino1, H S Scott, Q Chen, P Peterson, U Mäebpää, M P Papasavvas, L Mittaz, C Barras, C Rossier, G P Chrousos, C A Stratakis, K Nagamine, J Kudoh, N Shimizu, N Maclaren, S E Antonarakis, K Krohn.   

Abstract

Autoimmune polyendocrinopathy syndrome type 1 (APS-1; MIM# 240300) is a rare autosomal recessively inherited disease characterised by destructive autoimmune diseases of endocrine glands. The gene responsible for APS-1, known as AIRE (for autoimmune regulator), was recently identified and contains motifs suggestive of a transcription regulator. To date, nine APS-1-associated mutations have been identified in the AIRE gene, including two common mutations R257X and 1094-1106del. In addition to these two mutations, we report seven novel mutations in 16 APS-1 patients from North America. We found that 1094-1106del and R257X were the most common mutations in this population of mixed geoethnic origin, accounting for 17/32 and 4/32 alleles, respectively. Haplotype analyses suggest that both are recurrent mutations, occurring on several different haplotypes with closely linked markers. All the novel mutations appear to be rare, occurring in only single APS-1 families. After examining all coding sequences and exon/intron boundaries of the AIRE gene, the other APS-1 allele remained unidentified in three patients. Genotype-phenotype correlations for APS-1 remain difficult, suggesting that other genetic or environmental factors, or both, influence the clinical presentation and disease progression in individual APS-1 patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888391     DOI: 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

Review 1.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Choudhary Sonal; McLeod Michael; Torchia Daniele; Romanelli Paolo
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

3.  Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Elise M N Ferre; Stacey R Rose; Sergio D Rosenzweig; Peter D Burbelo; Kimberly R Romito; Julie E Niemela; Lindsey B Rosen; Timothy J Break; Wenjuan Gu; Sally Hunsberger; Sarah K Browne; Amy P Hsu; Shakuntala Rampertaap; Muthulekha Swamydas; Amanda L Collar; Heidi H Kong; Chyi-Chia Richard Lee; David Chascsa; Thomas Simcox; Angela Pham; Anamaria Bondici; Mukil Natarajan; Joseph Monsale; David E Kleiner; Martha Quezado; Ilias Alevizos; Niki M Moutsopoulos; Lynne Yockey; Cathleen Frein; Ariane Soldatos; Katherine R Calvo; Jennifer Adjemian; Morgan N Similuk; David M Lang; Kelly D Stone; Gulbu Uzel; Jeffrey B Kopp; Rachel J Bishop; Steven M Holland; Kenneth N Olivier; Thomas A Fleisher; Theo Heller; Karen K Winer; Michail S Lionakis
Journal:  JCI Insight       Date:  2016-08-18

4.  The autoimmune regulator (AIRE), which is defective in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients, is expressed in human epidermal and follicular keratinocytes and associates with the intermediate filament protein cytokeratin 17.

Authors:  Vipul Kumar; Luis A Pedroza; Emily M Mace; Steven Seeholzer; George Cotsarelis; Antonio Condino-Neto; Aimee S Payne; Jordan S Orange
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

5.  Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein.

Authors:  P Björses; M Halonen; J J Palvimo; M Kolmer; J Aaltonen; P Ellonen; J Perheentupa; I Ulmanen; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 6.  The role of AIRE in human autoimmune disease.

Authors:  Eitan M Akirav; Nancy H Ruddle; Kevan C Herold
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

7.  Molecular background and genotype-phenotype correlation in autoimmune-polyendocrinopathy-candidiasis-ectodermal-distrophy patients from Campania and in their relatives.

Authors:  D Capalbo; C Mazza; R Giordano; N Improda; E Arvat; S Cervato; L Morlin; C Pignata; C Betterle; M Salerno
Journal:  J Endocrinol Invest       Date:  2011-04-20       Impact factor: 4.256

Review 8.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective.

Authors:  D Capalbo; N Improda; A Esposito; L De Martino; F Barbieri; C Betterle; C Pignata; M Salerno
Journal:  J Endocrinol Invest       Date:  2013-05-30       Impact factor: 4.256

Review 9.  Autoimmune regulator (AIRE) gene on chromosome 21: implications for autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) any more common manifestations of endocrine autoimmunity.

Authors:  G Meyer; K Badenhoop
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

10.  Functional Domains of Autoimmune Regulator (AIRE) Modulate INS-VNTR Transcription in Human Thymic Epithelial Cells.

Authors:  Avis E Sparks; Chiachen Chen; Mary B Breslin; Michael S Lan
Journal:  J Biol Chem       Date:  2016-04-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.